Talphera, Inc.
TLPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427925
No open-market purchases or sales by Talphera, Inc. insiders were filed in the last 90 days; 51 institutions reported holding it in 13F filings for Q3 2026, worth $25.8M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 20, 2026
- $40.8M
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +2 vs. previous quarter
- 51
- 13F valueReported value at the end of Q3 2026
- $25.8M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $28.0K
- No comparable prior period
- Net income, FY2025
- -$14.3M
- No comparable prior period
- Free cash flow, FY2025
- –
- No comparable prior period
- Revenue, Q3 FY2026
- $0
- −100.0% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $14.3M (51035.7% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 1.22M
- Shares sold short
- Change
- +153.0K
- +14.4% vs. previous
- Days to cover
- 27.72
- At average daily volume
Superinvestors holding TLPH, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding TLPH at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Talphera, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 (view filing) | Mar 13 | 12 daysLate | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +213.3K | $0.59 | +$125.9K | +36.3%800.7K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Aslam ShakilChief Medical Officer | PPurchase | +35.0K | $0.81 | +$28.4K | +72.6%83.2K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +105.4K | $0.81 | +$85.3K | +21.9%587.0K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Asadorian RaffiChief Financial Officer | PPurchaseCommom Stock | +45.0K | $0.81 | +$36.5K | +97.3%91.3K after | |
| Feb 20, 2026 (view filing) | Feb 12 | 8 daysLate | Dasu Badri NChief Engineering Officer | PPurchase | +35.0K | $0.81 | +$28.4K | +84.9%76.2K after | |
| Apr 3, 2025 (view filing) | Apr 2 | 1 day | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +213.3K | $0.59 | +$125.9K | +112.0%403.8K after | |
| Feb 26, 2025 (view filing) | Jun 13-14, 2024 | 258 daysLate | Aslam ShakilChief Medical Officer | PPurchase | +5.70K | $1.06 | +$6.03K | +17.8%37.7K after | 2 lots |
| Dec 6, 2024 (view filing) | Dec 5 | 1 day | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $0.64 | +$3.20K | +2.5%208.1K after | |
| Dec 2, 2024 (view filing) | Dec 2 | Same day | Asadorian RaffiChief Financial Officer | SSale | −155 | $0.77 | −$119.35 | −0.4%37.6K after | |
| Dec 2, 2024 (view filing) | Nov 27 | 5 days | Angotti Vincent J.CHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $0.73 | +$3.65K | +2.5%203.1K after |
Top 10 13F holders, Q3 2026
See all 51 holdersThe largest institutional positions in Talphera, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 4,286,502 | $4.97M | 0.56% | −315,000−6.8% | Reduced |
| Rosalind Advisors, Inc. | 4,134,144 | $4.80M | 1.55% | −1,035,357−20.0% | Reduced |
| Rock Springs Capital Management LP | 3,589,186 | $4.16M | 0.22% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 3,492,519 | $4.05M | 0.23% | 00.0% | Unchanged |
| Bleichroeder LP | 1,307,787 | $1.52M | 0.15% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 1,001,645 | $1.16M | 0.00% | +299,768+42.7% | Added |
| Cantor Fitzgerald, L. P. | 709,976 | $823.6K | 0.02% | −177,505−20.0% | Reduced |
| Geode Capital Management, LLC | 465,423 | $540.0K | 0.00% | +36,361+8.5% | Added |
| Caption Management, LLC | 443,118 | $514.0K | 0.02% | −71,851−14.0% | Reduced |
| Diadema Partners LP | 378,037 | $438.5K | 0.16% | +224,474+146.2% | Added |
Holders of 5% or more of TLPH
See all 5 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Talphera, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| CorMedix Inc. | 13D | 19.95%9.09M shares | New | Sep 12, 20251 filing | Sep 12, 2025 | SEC |
| Nantahala Capital Management, LLC | 13D/A | 11.70%1.99M shares | 0.00 ppfrom 11.70% | Jan 23, 20243 filings | Apr 3, 2025 | SEC |
| Rosalind Advisors, Inc. | 13G/A | 9.90%11.9M shares | 0.00 ppfrom 9.90% | Apr 11, 20256 filings | Nov 13, 2026 | SEC |
| Hirschman Orin | 13G/A | 9.80%4.66M shares | +0.10 ppfrom 9.70% | Nov 10, 20252 filings | Jan 30, 2026 | SEC |
| Rock Springs Capital Management LP | 13G | 7.88%3.59M shares | New | Sep 12, 20251 filing | Sep 12, 2025 | SEC |